Oncotarget

Vol 9, No 65

August 21, 2018

View Archive »

About The Cover

The cover for issue 65 of Oncotarget features Figure 5, "Waterfall plot showing response by % change in tumor size after Y-90 radioembolization," by Dendy, et al.

Table of Contents

News

Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs

Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs

https://doi.org/10.18632/oncotarget.25968

Ting-Hui Wu, Nagla Karim,  and Jeffrey A. Moscow
32404-32405
PDF  |  How to cite

Editorial

Clinical utility of chromatin analysis

Clinical utility of chromatin analysis

https://doi.org/10.18632/oncotarget.25991

Andreas Kleppe,  and Håvard E. Danielsen
32406-32407
PDF  |  How to cite

Research Papers

An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition

An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition

https://doi.org/10.18632/oncotarget.25784

Ayesha T. Chawla, Agnes D. Cororaton, Michael O. Idowu, Priyadarshan K. Damle, Barbara Szomju, Keith C. Ellis, Bhaumik B. Patel,  and Steven R. Grossman
32408-32418
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer

A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer

https://doi.org/10.18632/oncotarget.25940

Pushpinder Singh Bawa, Samathmika Ravi, Swagatika Paul, Bibha Chaudhary,  and Subhashini Srinivasan
32419-32434
Abstract  |  PDF  |  HTML  |  How to cite

Integrin α2β1 decelerates proliferation, but promotes survival and invasion of prostate cancer cells

Integrin α2β1 decelerates proliferation, but promotes survival and invasion of prostate cancer cells

https://doi.org/10.18632/oncotarget.25945

Marjaana Ojalill, Marjaana Parikainen, Pekka Rappu, Elina Aalto, Johanna Jokinen, Noora Virtanen, Elina Siljamäki,  and Jyrki Heino
32435-32447
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

“Two hits - one stone”; increased efficacy of cisplatin-based therapies by targeting PCNA’s role in both DNA repair and cellular signaling

“Two hits - one stone”; increased efficacy of cisplatin-based therapies by targeting PCNA’s role in both DNA repair and cellular signaling

https://doi.org/10.18632/oncotarget.25963

Caroline Krogh Søgaard, Augun Blindheim, Lisa M. Røst, Voin Petrović, Anala Nepal, Siri Bachke, Nina-Beate Liabakk, Odrun A. Gederaas, Trond Viset, Carl-Jørgen Arum, Per Bruheim,  and Marit Otterlei
32448-32465
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma

SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma

https://doi.org/10.18632/oncotarget.25977

Damian Mikolaj Janecki, Marcin Sajek, Maciej Jerzy Smialek, Maciej Kotecki, Barbara Ginter-Matuszewska, Bogna Kuczynska, Anna Spik, Tomasz Kolanowski, Riko Kitazawa, Maciej Kurpisz,  and Jadwiga Jaruzelska
32466-32477
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

Zac1 regulates IL-11 expression in osteoarthritis

Zac1 regulates IL-11 expression in osteoarthritis

https://doi.org/10.18632/oncotarget.25980

Chun-Lin Kuo, Shu-Ting Liu, Yung-Lung Chang, Chia-Chun Wu,  and Shih-Ming Huang
32478-32495
Abstract  |  PDF  |  HTML  |  How to cite

Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells

Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells

https://doi.org/10.18632/oncotarget.25985

Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka,  and Kazuma Ohyashiki
32496-32506
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro

miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro

https://doi.org/10.18632/oncotarget.25986

Theresa Kordaß, Claudia E.M. Weber, David Eisel, Antonino A. Pane, Wolfram Osen,  and Stefan B. Eichmüller
32507-32522
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite

Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases

Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases

https://doi.org/10.18632/oncotarget.25992

Meaghan S. Dendy, Johannes M. Ludwig, Nima Kokabi, Stacey M. Stein, Jill Lacy, Howard S. Hochster,  and Hyun S. Kim
32523-32533
Abstract  |  PDF  |  HTML  |  How to cite  |  Press Release

Reviews

Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer

Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer

https://doi.org/10.18632/oncotarget.25946

Andrej Jedinak, Kevin R. Loughlin,  and Marsha A. Moses
32534-32550
Abstract  |  PDF  |  HTML  |  How to cite

Retraction

Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer

Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer

https://doi.org/10.18632/oncotarget.26037

Yu-Ji Li, Ming Dong, Fan-Min Kong, Jian-Ping Zhou, Dong Liang,  and Huan-Zhou Xue
32551-32551
Retraction  |  PDF  |  How to cite


Copyright © 2023 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC